Title:
【発明の名称】自己由来のワクチン
Document Type and Number:
Japanese Patent JPH0759518
Kind Code:
B2
Abstract:
This invention relates to monoclonal antibodies produced by hybridoma or transformed B-cell lines derived from B-cells of cancer patients actively immunized with autologous tumor antigen. These monoclonal antibodies can be used in both diagnostic procedures and therapy for human cancers. This invention also relates to diagnostic procedures and therapeutic approaches using these monoclonal antibodies.
Inventors:
Michael Gee Hannah The Union
Martine buoy haspel
Herbert Sea Hoover The Junior
Martine buoy haspel
Herbert Sea Hoover The Junior
Application Number:
JP1769285A
Publication Date:
June 28, 1995
Filing Date:
January 31, 1985
Export Citation:
Assignee:
Akzo Namrose Fennaught Shap
International Classes:
A61K39/00; A61K39/395; A61P35/00; C07K14/005; C07K14/195; C07K14/705; C07K16/00; C07K16/30; C12N5/00; C12N5/10; C12N15/00; C12N15/02; C12P21/00; C12P21/08; G01N33/53; G01N33/574; G01N33/577; A61K38/00; C12R1/91; (IPC1-7): A61K39/00
Domestic Patent References:
| JP58201994A | ||||
| JP59137497A | ||||
| JP5993844A |
Other References:
Ｂｒ．Ｊ．Ｃａｎｃｅｒ，４３（５），６９６−７００（１９８１）
Ｅｕｒ，Ｊ．ＣａｎｃｅｒＣｌｉｎ．Ｏｎｃｏｌ．，１７（７），７１９−７３０（１９８１）
Ｎａｔｕｒｅ，３００，３１６−３１７（１９８２）
Ｅｕｒ，Ｊ．ＣａｎｃｅｒＣｌｉｎ．Ｏｎｃｏｌ．，１７（７），７１９−７３０（１９８１）
Ｎａｔｕｒｅ，３００，３１６−３１７（１９８２）
Attorney, Agent or Firm:
Kyozo Yuasa (5 people outside)